Groupe la Francaise Acquires New Position in CVS Health Corporation $CVS

Groupe la Francaise acquired a new position in shares of CVS Health Corporation (NYSE:CVS) in the 2nd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm acquired 50,024 shares of the pharmacy operator’s stock, valued at approximately $5,175,000.

Several other hedge funds have also made changes to their positions in CVS. California State Teachers Retirement System grew its position in CVS Health by 10,133.9% in the second quarter. California State Teachers Retirement System now owns 193,320,429 shares of the pharmacy operator’s stock worth $19,998,998,000 after acquiring an additional 191,431,405 shares during the period. BlackRock Inc. purchased a new stake in CVS Health in the second quarter valued at $12,747,462,000. State Street Corp lifted its stake in shares of CVS Health by 2.1% in the 4th quarter. State Street Corp now owns 60,183,743 shares of the pharmacy operator’s stock valued at $4,776,182,000 after purchasing an additional 1,245,457 shares during the last quarter. Wellington Management Group LLP grew its holdings in shares of CVS Health by 49.8% during the 2nd quarter. Wellington Management Group LLP now owns 33,801,113 shares of the pharmacy operator’s stock worth $3,496,725,000 after purchasing an additional 11,233,381 shares during the period. Finally, Capital International Investors increased its position in shares of CVS Health by 3.4% during the 4th quarter. Capital International Investors now owns 27,592,356 shares of the pharmacy operator’s stock worth $2,189,793,000 after purchasing an additional 900,153 shares during the last quarter. Hedge funds and other institutional investors own 80.66% of the company’s stock.

Wall Street Analyst Weigh In

Several research analysts have weighed in on the stock. Weiss Ratings raised shares of CVS Health from a “hold (c+)” rating to a “buy (b-)” rating in a research note on Wednesday, August 5th. Wall Street Zen upgraded shares of CVS Health from a “buy” rating to a “strong-buy” rating in a report on Saturday, August 8th. Truist Financial increased their price objective on shares of CVS Health from $108.00 to $118.00 and gave the stock a “buy” rating in a research report on Tuesday, July 14th. Sanford C. Bernstein lifted their target price on shares of CVS Health from $94.00 to $106.00 and gave the company an “outperform” rating in a report on Tuesday, May 12th. Finally, Royal Bank Of Canada boosted their target price on CVS Health from $107.00 to $113.00 and gave the company an “outperform” rating in a research report on Thursday, July 9th. Twenty-two equities research analysts have rated the stock with a Buy rating and one has issued a Hold rating to the company’s stock. According to MarketBeat.com, CVS Health presently has a consensus rating of “Moderate Buy” and a consensus target price of $106.83.

CVS Health Price Performance

CVS Health stock opened at $96.80 on Tuesday. The company has a current ratio of 0.87, a quick ratio of 0.66 and a debt-to-equity ratio of 0.74. The company has a fifty day simple moving average of $100.65 and a 200-day simple moving average of $90.35. The stock has a market cap of $123.80 billion, a P/E ratio of 25.61, a price-to-earnings-growth ratio of 0.94 and a beta of 0.59. CVS Health Corporation has a 12-month low of $69.51 and a 12-month high of $110.68.

CVS Health (NYSE:CVS) last posted its earnings results on Wednesday, August 5th. The pharmacy operator reported $2.58 EPS for the quarter, beating the consensus estimate of $1.87 by $0.71. The firm had revenue of $106.10 billion for the quarter, compared to analyst estimates of $100.03 billion. CVS Health had a return on equity of 13.12% and a net margin of 1.18%.CVS Health’s revenue for the quarter was up 7.3% compared to the same quarter last year. During the same quarter in the prior year, the company posted $1.81 earnings per share. CVS Health has set its FY 2026 guidance at 7.900-8.100 EPS. Equities analysts expect that CVS Health Corporation will post 8.02 EPS for the current fiscal year.

CVS Health Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Monday, August 3rd. Stockholders of record on Thursday, July 23rd were given a dividend of $0.665 per share. This represents a $2.66 annualized dividend and a dividend yield of 2.7%. The ex-dividend date of this dividend was Thursday, July 23rd. CVS Health’s dividend payout ratio (DPR) is 70.37%.

CVS Health Company Profile

CVS Health Corporation is a diversified healthcare company that operates a large network of retail pharmacies, pharmacy benefit management services and health care solutions. Headquartered in Woonsocket, Rhode Island, the company traces its roots to the early 1960s and has grown into an integrated provider of prescription drugs, over?the?counter products, clinical services and health insurance offerings. Its operating model combines retail pharmacy locations and in?store clinics with broader pharmacy and health plan capabilities.

Key business activities include CVS Pharmacy retail operations, MinuteClinic walk?in medical clinics and HealthHUB locations that offer expanded clinical services.